GR3025376T3 - Salts of nefazodone having improved dissolution rates - Google Patents

Salts of nefazodone having improved dissolution rates

Info

Publication number: GR3025376T3
Authority: GR; Greece
Prior art keywords: salts; nefazodone; dissolution rates; improved dissolution; dissolution
Prior art date: 1994-11-02

Application number

GR970403019T

Other languages

English (en)

Inventor

Hemant N Joshi

Terry D Wilson

Jatin M Patel

Original Assignee

Bristol Myers Squibb Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-11-02

Filing date

1997-11-13

Publication date

1998-02-27

1997-11-13 Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co

1998-02-27 Publication of GR3025376T3 publication Critical patent/GR3025376T3/el

Links

238000004090 dissolution Methods 0.000 title abstract 4
VRBKIVRKKCLPHA-UHFFFAOYSA-N nefazodone Chemical class O=C1N(CCOC=2C=CC=CC=2)C(CC)=NN1CCCN(CC1)CCN1C1=CC=CC(Cl)=C1 VRBKIVRKKCLPHA-UHFFFAOYSA-N 0.000 title abstract 3
229960001800 nefazodone Drugs 0.000 title abstract 3
150000003839 salts Chemical class 0.000 title abstract 3
BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 abstract 1
FEWJPZIEWOKRBE-JCYAYHJZSA-L L-tartrate(2-) Chemical compound [O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O FEWJPZIEWOKRBE-JCYAYHJZSA-L 0.000 abstract 1
AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical class CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 abstract 1
238000010521 absorption reaction Methods 0.000 abstract 1
238000009472 formulation Methods 0.000 abstract 1
210000000936 intestine Anatomy 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 abstract 1
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D249/12—Oxygen or sulfur atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Psychiatry (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Biomedical Technology (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pain & Pain Management (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)

GR970403019T 1994-11-02 1997-11-13 Salts of nefazodone having improved dissolution rates GR3025376T3 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US33339094A	1994-11-02	1994-11-02

Publications (1)

Publication Number	Publication Date
GR3025376T3 true GR3025376T3 (en)	1998-02-27

Family

ID=23302579

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GR970403019T GR3025376T3 (en)	1994-11-02	1997-11-13	Salts of nefazodone having improved dissolution rates

Country Status (10)

Country	Link
US (1)	US6034085A (el)
EP (1)	EP0710653B1 (el)
JP (1)	JPH08208480A (el)
AT (1)	ATE157659T1 (el)
AU (1)	AU689645B2 (el)
CA (1)	CA2160423A1 (el)
DE (1)	DE69500652T2 (el)
DK (1)	DK0710653T3 (el)
ES (1)	ES2107280T3 (el)
GR (1)	GR3025376T3 (el)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20030091629A1 (en) *	1998-03-27	2003-05-15	Cima Labs Inc.	Sublingual buccal effervescent
US6974590B2 (en)	1998-03-27	2005-12-13	Cima Labs Inc.	Sublingual buccal effervescent
US20030118645A1 (en) *	1998-04-29	2003-06-26	Pather S. Indiran	Pharmaceutical compositions for rectal and vaginal administration
ATE369135T1 (de) *	1998-04-24	2007-08-15	Scarista Ltd	Behandlung von depression und zusammensetzungen dazu
ES2152860B1 (es) *	1998-10-23	2001-08-16	Finaf 92 Sa	Forma cristalina de la nefazodona y procedimiento para su preparacion.
PT1126853E (pt) *	1998-11-02	2006-07-31	Alza Corp	Distribuicao controlada de anti-depressivos
US7183060B2 (en) *	2005-02-22	2007-02-27	Idexx Laboratories, Inc.	Peptides for detection of antibody to Ehrlichia ewingii
US7087372B2 (en) *	2001-01-18	2006-08-08	Idexx Laboratories, Inc.	Compositions and methods for detection of Ehrlichia canis and Ehrlichia chaffeensis antibodies
US20030194756A1 (en) *	2002-04-12	2003-10-16	O'connor Thomas Patrick	Peptides for detection of antibody to Ehrlichia equi
US7407770B2 (en) *	2001-01-18	2008-08-05	Idexx Corporation	Compositions and methods for detection of Ehrlichia canis and Ehrlichia chaffeensis antibodies
US20030129680A1 (en) *	2001-10-31	2003-07-10	O'connor Thomas Patrick	Multi-analyte assay device
US20030068356A1 (en) *	2001-07-10	2003-04-10	Pather S. Indiran	Sequential drug delivery systems
GB0217056D0 (en) *	2002-07-23	2002-08-28	Ass Octel	Use
TWI335218B (en) *	2003-02-19	2011-01-01	Panion & Bf Biotech Inc	Ferric organic compounds, uses thereof and methods of making same
DE602004031462D1 (de) *	2003-12-31	2011-03-31	Cima Labs Inc	Allgemein lineare brauseform von fentanyl zur oralen anwendung und verfahren zur verabreichung
US7858121B2 (en) *	2003-12-31	2010-12-28	Cima Labs, Inc.	Effervescent oral fentanyl dosage form and methods of administering fentanyl
CA2549642C (en) *	2003-12-31	2012-10-30	Cima Labs Inc.	Effervescent oral opiate dosage forms and methods of administering opiates
US20060069060A1 (en) *	2004-09-27	2006-03-30	Sanjeev Redkar	Salts of decitabine
US20060063735A1 (en) *	2004-09-17	2006-03-23	Supergen, Inc.	Salts of 5-azacytidine
US7507789B2 (en) *	2007-04-09	2009-03-24	Idexx Laboratories, Inc.	Detection of Anaplasma platys
CA2700476C (en)	2007-09-21	2017-11-28	Idexx Laboratories, Inc.	Methods and compositions for detection of ehrlichia chaffeensis variable-length pcr target
EP2203469A4 (en) *	2007-09-21	2011-08-24	Idexx Lab Inc	METHOD AND COMPOSITIONS FOR IDENTIFYING EHRLICHIA CHAFFEENSIS (P120)
US8158370B2 (en)	2007-11-27	2012-04-17	Idexx Laboratories, Inc.	Anaplasma phagocytophilum (Aph) antigens and antibodies specific for Anaplasma
MX2011003634A (es) *	2008-10-08	2011-05-02	Idexx Lab Inc	Composiciones y metodos para la deteccion de anticuerpos especificos de anaplasma phagocytophilum (aph) y anaplasma platys (apl).
EP2448406B1 (en)	2009-02-26	2016-04-20	Relmada Therapeutics, Inc.	Extended release oral pharmaceutical compositions of 3-hydroxy-n-methylmorphinan and method of use
WO2012072665A1 (en)	2010-11-30	2012-06-07	Pharmaneuroboost N.V.	Compositions comprising pipamperone and serotonin antagonist reuptake inhibitors
US9133525B2 (en)	2012-01-26	2015-09-15	Luc Montagnier	Detection of DNA sequences as risk factors for HIV infection
CN117797108B (zh) *	2024-01-02	2025-06-27	山东新时代药业有限公司	一种富马酸比索洛尔组合物片剂

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IT1066857B (it) *	1965-12-15	1985-03-12	Acraf	Derivati della s ipiazolo 4.3 a piridina e processi per la loro preparazione
US4338317A (en) *	1981-03-16	1982-07-06	Mead Johnson & Company	Phenoxyethyl-1,2,4,-triazol-3-one antidepressants
US4487773A (en) *	1981-03-16	1984-12-11	Mead Johnson & Company	1,2,4-Triazol-3-one antidepressants
IT1196429B (it) *	1986-07-01	1988-11-16	Mediolanum Farmaceutici Srl	Processo per la preparazione di pirido benzotiazine ad attivita' antibatterica e loro sali con acidi solfonici
US5188836A (en) *	1990-07-27	1993-02-23	Warner-Lambert Company	Sustained release formulations
TW279864B (el) *	1993-02-19	1996-07-01	Janssen Pharmaceutica Nv

1995
- 1995-10-12 CA CA002160423A patent/CA2160423A1/en not_active Abandoned
- 1995-10-30 JP JP7281241A patent/JPH08208480A/ja active Pending
- 1995-11-01 AT AT95307812T patent/ATE157659T1/de not_active IP Right Cessation
- 1995-11-01 DE DE69500652T patent/DE69500652T2/de not_active Expired - Fee Related
- 1995-11-01 EP EP95307812A patent/EP0710653B1/en not_active Expired - Lifetime
- 1995-11-01 ES ES95307812T patent/ES2107280T3/es not_active Expired - Lifetime
- 1995-11-01 AU AU34583/95A patent/AU689645B2/en not_active Ceased
- 1995-11-01 DK DK95307812.8T patent/DK0710653T3/da active
1997
- 1997-11-13 GR GR970403019T patent/GR3025376T3/el unknown
1998
- 1998-09-29 US US09/161,698 patent/US6034085A/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
ES2107280T3 (es)	1997-11-16
DK0710653T3 (da)	1997-12-08
ATE157659T1 (de)	1997-09-15
JPH08208480A (ja)	1996-08-13
EP0710653A1 (en)	1996-05-08
AU689645B2 (en)	1998-04-02
US6034085A (en)	2000-03-07
AU3458395A (en)	1996-05-09
EP0710653B1 (en)	1997-09-03
DE69500652T2 (de)	1998-02-19
CA2160423A1 (en)	1996-05-03
DE69500652D1 (de)	1997-10-09

Similar Documents

Publication	Publication Date	Title
GR3025376T3 (en)	1998-02-27	Salts of nefazodone having improved dissolution rates
TR199600498A2 (tr)	1997-03-21	S(+)-ibuprofen'in oral formülasyonlari.
AR064896A2 (es)	2009-05-06	Composicion farmaceutica no higroscopica
LU90856I2 (fr)	2002-01-24	Uprima - apomorphine hydrochloride et ses d-riv-s pharmaceutiquement acceptables
LU91452I2 (fr)	2008-08-04	"Mycafungine et ses sels pharmaceutiquement acceptables(MYCAMINEr)"
LU91290I2 (fr)	2007-01-22	Céfovécine, optionnellement sous la forme d'un sel, dont le sel de sodium (CONVENIAr)
LU91306I2 (fr)	2007-03-19	Mitratapide, optionnellement sous forme d'un sel d'addition acide pharmaceutiquement acceptable (YARVITAN)
NO308854B1 (no)	2000-11-06	Terapeutiske forbindelser, farmasøytisk akseptable salter og formuleringer inneholdende forbindelsene, samt anvendelser derav
MX9504034A (es)	1997-05-31	Formas de administracion medicamentosas que contienen acido tioctico, o sales solidas del acido tioctico de liberacion y biodisponibilidad mejoradas.
IL96995A0 (en)	1992-03-29	Pharmaceutical compositions containing pimobendan and their preparation
IL119207A0 (en)	1996-12-05	Treatment of tinnitus using neuroprotective agents
TR199600499A2 (tr)	1996-12-21	S(+)-Etodolak'in oral formülasyonlari.
IL116993A0 (en)	1996-05-14	Extended-release solid oral dosage forms of drugs having low solubility in water
ZA973495B (en)	1997-11-18	Matrix tablet allowing the prolonged release of the sodium salt of tianeptine after administration by the oral route.
IL98574A0 (en)	1992-07-15	Piperidyl-substituted indoles
EP1069107A4 (en)	2002-08-07	FULLERENE DERIVATIVES
FR2678836B1 (fr)	1995-06-09	Formulations pour voie orale d'ubidecarenone sous la forme de solutions aqueuses.
AU6849594A (en)	1995-04-18	Orientation aid for use when swimming on the back
GB2135997B (en)	1986-02-19	N-(m-trifluoromethylphenyl)-n'-propargylpiperazine
IL104049A0 (en)	1993-05-13	7'-amino-naphthazarin antibiotic derivatives
TR199902117T2 (xx)	2000-03-21	(E)-4,6- Dikloro-3-(2-okso-1-fenilpirolidin-3-iliden metil)-1H-�ndol-2-karboksilik asidin kristalimsi hidratlanm�� sodyum tuzu.
FR2798279B1 (fr)	2001-12-07	Dispositif d'insemination artificielle, notamment pour la reproduction des porcs
IL140487A0 (en)	2002-02-10	Solid compositions suitable for oral administration containing non-hygroscopic salts of l-carnitine and alkanoyl l-carnitines
FR2794328B1 (fr)	2001-08-10	Decodeur de sequence d'image pour avance rapide
ITPD950047A0 (it)	1995-02-23	Telecamera endoscopica, in particolare per la ripresa di immagini della cavita' orale